Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
G Medical Innovations Holdings Ltd (GMVDF)
Rehovot, IL
G Medical Innovations Holdings Ltd operates as an emerging healthcare enterprise, focused on pioneering advanced mobile health and remote medical solutions across the United States, China, and Israel. Its product line includes Prizma, an intuitive medical device for measuring vital signs, which also incorporates electronic medical record functionality and adheres to clinical-grade reporting standards. Another offering is the Extended Holter Patch System, a multi-channel biosensor worn by patients that continuously records ECG data for up to two weeks. The company is also in the process of developing a Wireless Vital Signs Monitoring System, aiming to provide uninterrupted, real-time tracking of physiological parameters and biometrics. Furthermore, G Medical Innovations offers comprehensive monitoring services, encompassing both support for independent diagnostic testing facilities and personalized private monitoring solutions. Established in 2014, the company's corporate headquarters are located in Rehovot, Israel.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | -50.00% | +0.00% | -50.00% | +0.00% | +0.00% | -99.97% | -100.00% | -100.00% | -100.00% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Instruments & Supplies: +7.9%-10.9% Q2'22: +10.6% (vs Q2'20)
-
EPS growth Medical - Instruments & Supplies: +16.3%+24.9% ★ Q2'22: -1,512.1% (vs Q2'20)
-
FCF margin FCF growth · Medical - Instruments & Supplies: +27.1%-274.2% Q2'22: -819.2% (vs Q2'20)
-
EBIT margin Medical - Instruments & Supplies: +13.5%-223.2% Q2'22: -398.6% (vs Q2'20)
-
ROIC Medical - Instruments & Supplies: +6.0%— Q2'22: +1,278.3% (vs Q2'20)
-
Share dilution Medical - Instruments & Supplies: +0.1%+122.2% Q2'22: -83.5% (vs Q2'20)
-
Debt / EBITDA Net debt/EBITDA · Medical - Instruments & Supplies: -0.24×-0.24× Q2'22: -0.06× (vs Q2'20)
| Metric |
Dec 2023 actual |
Dec 2024 actual |
|---|---|---|
| Revenue |
13.18M
est.
|
34.50M
est.
|
| EBITDA |
-13.18M
est.
|
-34.50M
est.
|
| EBIT |
-13.18M
est.
|
-34.50M
est.
|
| Net Income |
-461.3K
est.
|
43.3K
est.
|
| SGA |
39.29M
est.
|
102.82M
est.
|
| EPS |
-0.64
est.
|
0.06
est.
|
Owner Earnings
Ownership Overview
Ownership breakdown not available.
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Yacov Geva | 4.38M | 32.20% | 4.38M | — | 4.38M | — | IN | Israel | 2022-02-22 | ↗ |
| 2 | AWM Investment Company, Inc. | 1.00M | 13.40% | 1.00M | — | 1.00M | — | — | Delaware, United States | 2023-04-11 | ↗ |
| 3 | Michael Bigger | 709.6K | 9.50% | — | — | — | 709.6K | IN | Delaware | 2023-04-06 | ↗ |
| 4 | Bigger Capital Fund GP, LLC | 368.0K | 4.90% | — | — | — | 368.0K | OO | Delaware | 2023-04-06 | ↗ |
| 5 | District 2 Capital Fund LP | 341.5K | 4.60% | — | — | — | 341.5K | PN | Delaware | 2023-04-06 | ↗ |
| 6 | District 2 Capital LP | 341.5K | 4.60% | — | — | — | 341.5K | PN | Delaware | 2023-04-06 | ↗ |
| 7 | District 2 GP LLC | 341.5K | 4.60% | — | — | — | 341.5K | OO | Delaware | 2023-04-06 | ↗ |
| 8 | District 2 Holdings LLC | 341.5K | 4.60% | — | — | — | 341.5K | OO | Delaware | 2023-04-06 | ↗ |
| 9 | Bigger Capital Fund, LP | 255.0K | 4.90% | — | — | — | 368.0K | PN | Delaware | 2023-04-06 | ↗ |
| 10 | Jonathan B. Rubini | 196.2K | 9.99% | 192.9K | 3.3K | 192.9K | 3.3K | IN | United States | 2023-02-03 | ↗ |
| 11 | JPMORGAN CHASE & CO.13-2624428 | 60.3K | 6.00% | 60.3K | — | 60.3K | — | HC | Delaware | 2023-01-31 | ↗ |
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Yacov Geva | Chief Executive Officer, President & Executive Director | 360.0K | — |
| Kobi Ben Efraim | Chief Financial Officer & Controller | 114.1K | male |
| Dror Nuriel-Roth | Executive Vice President of US Operations | — | female |
| Benny Tal | Vice President of R&D Corporate and Chief Technology Officer Corporate | — | male |
| Oded Shahar | Senior Vice President of Mergers & Acquisitions Corporate | — | male |
| Tim Lohman | Vice President of Operations | — | male |
| Brett Tucker | Company Secretary | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for GMVDF
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
